Company: ICUI
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0000883984-25-000010
Chunk: 26

Company: ICU MEDICAL INC/DE
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 26
---
 | $      | 430,000 |     | $                         | 129,000 |     | $                      | 258,000 |     | $                       |   387,000 |     | $                 |   451,500 |     |                                     | 175 | % |

#### Equity Awards
We grant equity awards to our executive officers to align their economic interests with the interests of our stockholders and to help achieve our retention objectives. The use of equity awards further promotes our efforts to encourage the profitability and growth of the Company through the establishment of strong incentives to increase the sustained value of our common stock.

<div align='center'>19</div>

2024 Equity Awards

In March 2024, as part of its annual review of our executive compensation program, the Compensation Committee approved the grant of PRSU awards and RSU awards to our named executive officers. This decision was based, in part, on the Compensation Committee's continued belief that PRSUs drive performance on specific financial metrics that will translate into long-term stockholder value creation. The Compensation Committee also believed that granting a combination of a PRSU award and an RSU award to Mr. Woolson and Ms. Sanzone effectively balanced the Company’s pay-for-performance and retention objectives.

The following table presents the dollar values of the RSU awards and the PRSU awards (at target) approved by the Compensation Committee in March 2024:

| Name                  |     | RSUs Target Value ($) |           |     | PRSUs Target Value ($) |           |
| Vivek Jain            |     |                       |         — |     |                        | 4,500,000 |
| Brian Bonnell         |     |                       |         — |     |                        | 3,000,000 |
| Christian Voigtlander |     |                       |         — |     |                        | 3,000,000 |
| Daniel Woolson        |     |                       |   675,000 |     |                        |   675,000 |
| Virginia Sanzone      |     |                       | 1,000,000 |     |                        | 1,000,000 |

These target values above were then used to determine the number of units to be granted to each named executive officer for 2024 (using the price of our common stock on the grant date) and (with each earned and/or vested unit subject to conversion on a one-for-one basis into shares of our Common Stock upon settlement) as follows:

| Name                  |     |